41 related articles for article (PubMed ID: 22764073)
1. Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
Scharpenberg M; Brannath W
Stat Methods Med Res; 2023 Sep; 32(9):1784-1798. PubMed ID: 37503578
[TBL] [Abstract][Full Text] [Related]
2. Conducting the non-inferiority test for the means with unknown coefficient of variation in a three-arm trial.
Lee MC; Wu WY; Lu HY; Hsieh HN; Wu WH
BMC Med Res Methodol; 2023 Aug; 23(1):183. PubMed ID: 37568109
[TBL] [Abstract][Full Text] [Related]
3. Sample size determination for a three-arm equivalence trial of normally distributed responses.
Chang YW; Tsong Y; Dong X; Zhao Z
J Biopharm Stat; 2014; 24(6):1190-202. PubMed ID: 25098678
[TBL] [Abstract][Full Text] [Related]
4. Nut consumption and incidence of metabolic syndrome after 6-year follow-up: the SUN (Seguimiento Universidad de Navarra, University of Navarra Follow-up) cohort.
Fernández-Montero A; Bes-Rastrollo M; Beunza JJ; Barrio-Lopez MT; de la Fuente-Arrillaga C; Moreno-Galarraga L; Martínez-González MA
Public Health Nutr; 2013 Nov; 16(11):2064-72. PubMed ID: 23092760
[TBL] [Abstract][Full Text] [Related]
5. Group sequential designs for three-arm 'gold standard' non-inferiority trials with fixed margin.
Schlömer P; Brannath W
Stat Med; 2013 Dec; 32(28):4875-89. PubMed ID: 23970488
[TBL] [Abstract][Full Text] [Related]
6. Calculating sample sizes for cluster randomized trials: we can keep it simple and efficient!
van Breukelen GJ; Candel MJ
J Clin Epidemiol; 2012 Nov; 65(11):1212-8. PubMed ID: 23017638
[TBL] [Abstract][Full Text] [Related]
7. Comments on "A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority design".
Raseta M; Bazarova A
Stat Med; 2019 Mar; 38(7):1300-1302. PubMed ID: 30829445
[No Abstract] [Full Text] [Related]
8. Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I'M WOMAN).
Brenner A; Shakur-Still H; Chaudhri R; Muganyizi P; Olayemi O; Arribas M; Kayani A; Javid K; Bello A; Roberts I;
Trials; 2023 Dec; 24(1):782. PubMed ID: 38044460
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial.
Sun D; Yu D; Du Z; Jia N; Liu X; Sun J; Xu Q; Sun Z; Luan C; Lv J; Xiong P; Zhang L; Sha X; Gao Y; Kang D
Hum Vaccin Immunother; 2023 Dec; 19(1):2161789. PubMed ID: 36593652
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial.
Liu X; Yang W; Zhang C; Wu H; Wang R; Ding Q; Hu Y; Xiong Y; Zhang S; Wang L
Hum Vaccin Immunother; 2021 Dec; 17(12):5348-5354. PubMed ID: 34905446
[TBL] [Abstract][Full Text] [Related]
11. Do incentives undermine intrinsic motivation? Increases in intrinsic motivation within an incentive-based intervention for people living with HIV in Tanzania.
Czaicki NL; Dow WH; Njau PF; McCoy SI
PLoS One; 2018; 13(6):e0196616. PubMed ID: 29902177
[TBL] [Abstract][Full Text] [Related]
12. Group-sequential three-arm noninferiority clinical trial designs.
Ochiai T; Hamasaki T; Evans SR; Asakura K; Ohno Y
J Biopharm Stat; 2017; 27(1):1-24. PubMed ID: 26892481
[TBL] [Abstract][Full Text] [Related]
13. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
Ghosh S; Ghosh S; Tiwari RC
Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
[TBL] [Abstract][Full Text] [Related]
14. Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
Wason JM; Stecher L; Mander AP
Trials; 2014 Sep; 15():364. PubMed ID: 25230772
[TBL] [Abstract][Full Text] [Related]
15. A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority design.
Stucke K; Kieser M
Stat Med; 2012 Dec; 31(28):3579-96. PubMed ID: 22764073
[TBL] [Abstract][Full Text] [Related]
16. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
Hida E; Tango T
J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
[TBL] [Abstract][Full Text] [Related]
17. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
Hida E; Tango T
Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
[TBL] [Abstract][Full Text] [Related]
18. Placebo group needed for interpretation of combination trial.
El-Mallakh RS; Kaur G; Lippman S
Am J Psychiatry; 2010 Aug; 167(8):996; author reply 996-7. PubMed ID: 20693473
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
